Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
3 Biotech Stocks to Buy for Long-Term Gains
07:01am, Thursday, 13'th Jul 2023
Suppose you're looking for a sector that will benefit from an end to the Federal Reserve's interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with long-dated
Is Now the Right Time to Embrace Biotech ETFs?
12:34pm, Wednesday, 12'th Jul 2023
Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023
07:03am, Wednesday, 12'th Jul 2023
As most savvy investors know by now, the outperformance of the Nasdaq and to a lesser degree, the S&P 500 has been driven by seven mega-caps, hailing from the tech, consumer discretionary, and communi
U.S. Wide-Moat Stocks On Sale - The July 2023 Heat Map
09:31am, Thursday, 06'th Jul 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th
The 3 Best Biotech Stocks to Buy In July
01:05pm, Wednesday, 05'th Jul 2023
Although it's been a difficult year for biotechnology stocks, there are still plenty of reasons for investors to be bullish on the sector. Many of the biggest innovations in medicine are occurring at
Why the 5 Highest-Yielding Nasdaq Stocks Could Rip Higher With the Red-Hot Summer Rally
07:03am, Wednesday, 05'th Jul 2023
Likely, 2023 will be known as the year artificial intelligence became a permanent part of the investing lexicon.
2 Medical Stocks to Consider Buying in June
09:52pm, Wednesday, 28'th Jun 2023
With solid top and bottom-line growth on the horizon for HealthEquity (HQY) and iRadimed (IRMD), they are starting to look like viable investments for 2023 and beyond.
Nurix: Still Promising, But No New Development Except Gilead Licensing Asset
07:07pm, Monday, 26'th Jun 2023
In my last article, I said I liked Nurix, a protein degrader company. Since then, not much has happened at Nurix except Gilead buying into an asset. This is a validation of the company, however, there
Gilead (GILD) Breast Cancer Drug Gets Positive CHMP Opinion
02:16pm, Monday, 26'th Jun 2023
Gilead's breast cancer drug Trodelvy gets positive CHMP opinion for a second indication in Europe.
Gilead Sciences (GILD) Announces Positive HDV Treatment Data
02:09pm, Friday, 23'rd Jun 2023
Gilead Sciences, Inc. (GILD) announces data on Hepcludex that reinforces the potential of bulevirtide as an effective and well-tolerated treatment for chronic HDV after 96 weeks.
Gilead to Present Latest Liver Disease Research at the European Association for the Study of the Liver (EASL) Congress 2023
03:00am, Wednesday, 14'th Jun 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced new data to be presented at the European Association for the Study of the Liver (EASL) Congress 2023, June 21-
Gilead Sciences, Inc. (GILD) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)
04:19pm, Monday, 12'th Jun 2023
Gilead Sciences, Inc. (NASDAQ:GILD ) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 2023 1:40 PM ET Company Participants Daniel O'Day - Chairman & CEO Merdad Parsey - Chief Medical Of
Final Trade: GILD, TOL, BAC & MU
06:49pm, Friday, 09'th Jun 2023
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
2 Top Biotech Stocks to Buy in June
10:15am, Friday, 09'th Jun 2023
The biotech sector remains a fertile place of innovation that can enrich an investor. Gilead has a potential oncology blockbuster, and the stock offers a sizable dividend.
Pfizer Or Gilead Sciences? Let's Ask Peter Lynch
09:45pm, Thursday, 08'th Jun 2023
Peter Lynch is often not considered a dividend investor, which is unfortunate. He has so many valuable insights into dividend stocks that can benefit us. It's just his success with 10-baggers has domi
